Delray Medical Center vascular surgeon Dr Joseph Ricotta is the first in the world to utilize the Celt ACD PLUS System in a procedure.
The Celt ACD is an innovative small-bore closure device available in 5F, 6F, and 7F sizes, designed for rapid arterial puncture closure following percutaneous catheter-based vascular procedures. It helps seal the artery after a procedure, reducing the risk for complications. Its novel mechanism of action reduces major vascular closure complications such as bleeding, hematomas, and pseudoaneurysms. Clinical data has demonstrated significant reductions in time to hemostasis, ambulation, and discharge, leading to improved efficiency and cost savings in post-anesthesia care. This next-generation device enhances the proven Celt ACD® platform by providing physicians with a visual indication for precise placement and closure, particularly beneficial in cases where ultrasound imaging is not available.
The milestone procedure was completed at the Prime Vascular Institute in Delray Beach, which was founded by Dr. Ricotta…